Member Info for bighammer

The interesting thing for me is that this is not a pharma but physician organisation , this is why we need funding BUT we will have more cudos with the results as it will be seen as a more independant view as it is delivered by the medical proffession and not a pharma . Also with the conditional approval this will help as NICE carries weight all over the world and the De Novo route is also cheaper and quicker once application goes in .This is the start now if we can get a good finance deal in place by which i mean £4-5m then things and possibly the sp will start to improve .

Not expecting much this Friday TBH , but if the company get the nod then things could start to go forward.

Just wondering , when we get the stroke test fully approved would it not make sense to swap the FDA applications round , it is more profitable , with NICE approval and another test to compare it too application would be so much easier and quicker????.

Some great posts and research Lionel, What we also have apart from the 2 tests is the IP on how these tests are developed , and as it seems to be ticking all the boxes this surely can be used to develop other tests , no brainer.

Waste of time System because i only know as much anybody else lol.

Tiger the FACT is nobody outside of the company know what is going on other than we will be raising money in the near term to finance FDA application , and to keep the lights on . Everything else mentioned on here either by you or others is speculation or educated guessing, you have mentioned many things that might/could happen but produced no proof or evidence to support your claims, FACT.

Or Tuesday, possibly Wednesday as its Systems favourite day . Thursday sounds good but if not definately Friday.

Takeovers normally happen when companies are making steady sales, we are a long way from that .

Gloria , could nt agree more , good post.

In that case if you have made over the threshold for capital gains you can off set your losses.

Munmir, in an ideal world yes but when you go to carry out the transaction it may not be that bad PLUS it may well be covered as and when you do your tax return unless you are one of the few lucky ones in profit.

System , i really really hope it comes off for you mate, once we here what funding is going to be you will be able to make a balanced decision on what to do . i am hoping with funding you may even be able to break even this year with your current average.

The amount of dilution will decide on haw much the company are looking to raise, anything between £3-5m , about 12months running costs taking into account sales also coming in .

Following on from that , surely the test is more cost effective in the long run, yes the machines have to be purchased along with the tests compared to transportation of the tests to the lab then tests run then uploading information which can then lead to human error , whereas with the test it eliminates a lot of paperwork and human error with a much faster turn around. I do tend to take my time to read. read listen and then ponder for a while to look at as many angles as possible , my initial reaction to the presentation was not great , but now apart from timelines i am a lot more positive and i believe funding will happen possibly at a fairly big discount but happen none the less.

Every test goes wrong at some point , there is no such thing as 100% , that is why the NHS spend billions of pounds in compo, but it has a success rate better than what is on the market and being used right now, even lab tests dont work on 100%.

For me it is the wording , in Feb 23 it was announced NICE had preliminary reccomended the stroke test , for the hearing it is saying reccomended , one word missing which for me gives a whole new meaning to the outcome. Even if we had an inside contact would anyone believe them ???.

System , my thoughts are ,1 news was delayed for a reason , and that being we have now seen this has been compared to the existing test and lab tests and ours came out tops. 2 the delay was nothing to do with the test purely down to NICE , now was it that they had never given full reccomendation straight off even though they new it works ???, just my thoughts and reasonings whereas the hearing test was so unique and nothing else to compare it too.

Also why are the company looking to raise capitol not just to keep the lights on but also for production purposes ie machine and tests and not just for the hearing test.

It makes you wonder why the results have been delayed when it has been said specifically it is nothing to do with the test more so logistically with NICE , with appraisals and comparisons the the other test already used by the NHS , their own results show Gendrive is better in speed , accuracy and cost effectiveness, so what else do they need to appove , all the data is there for them , it is now just a box ticking exercise.

I have always thought this will be a takeover target what with the tests and IP but always thought we would need to have both tests and approved worldwide before offers came in. Maybe sales with the hearing test and FDA application underway may tempt an offer, any thoughts ???????

All correct on funding and just hoping full approval will come in July. JC also mentioned funding is also for taking the company forward so i again am assuming this will include commercialisation as regards producing /funding machines and tests. Timewise it matches up with NHS funding the stroke test in October and FDA application towards the end of the year, so finances needed prior to this to have said items in place .